MetaVia is trading at $1.81 (6.1% up) in pre-market, rebounding from last week’s tech-led selloff and several consecutive weak sessions.
- The move appears to be tracking a modest risk-on tone in futures and broader speculative interest in the biotech sector following recent downward pressure.
- There are no fresh company-specific headlines, earnings reports, or analyst calls directly tied to this morning's price action.